587 related articles for article (PubMed ID: 10215666)
1. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
[TBL] [Abstract][Full Text] [Related]
2. Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudate.
Rothman RB; Silverthorn ML; Baumann MH; Goodman CB; Cadet JL; Matecka D; Rice KC; Carroll FI; Wang JB; Uhl GR
J Pharmacol Exp Ther; 1995 Jul; 274(1):385-95. PubMed ID: 7616423
[TBL] [Abstract][Full Text] [Related]
3. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
[TBL] [Abstract][Full Text] [Related]
4. [3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.
Johnson RA; Eshleman AJ; Meyers T; Neve KA; Janowsky A
Synapse; 1998 Sep; 30(1):97-106. PubMed ID: 9704886
[TBL] [Abstract][Full Text] [Related]
5. Transporter-mediated actions of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane.
Shimazu S; Tsunekawa H; Yoneda F; Katsuki H; Akaike A; Janowsky A
Eur J Pharmacol; 2003 Dec; 482(1-3):9-16. PubMed ID: 14659999
[TBL] [Abstract][Full Text] [Related]
6. Studies of the biogenic amine transporters. V. Demonstration of two binding sites for the cocaine analog [125I]RTI-55 associated with the 5-HT transporter in rat brain membranes.
Silverthorn ML; Dersch CM; Baumann MH; Cadet JL; Partilla JS; Rice KC; Carroll FI; Becketts KM; Brockington A; Rothman RB
J Pharmacol Exp Ther; 1995 Apr; 273(1):213-22. PubMed ID: 7714769
[TBL] [Abstract][Full Text] [Related]
7. Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex.
Boja JW; Carroll FI; Vaughan RA; Kopajtic T; Kuhar MJ
Synapse; 1998 Sep; 30(1):9-17. PubMed ID: 9704876
[TBL] [Abstract][Full Text] [Related]
8. Studies of the biogenic amine transporters. XI. Identification of a 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) analog that allosterically modulates the serotonin transporter.
Nightingale B; Dersch CM; Boos TL; Greiner E; Calhoun WJ; Jacobson AE; Rice KC; Rothman RB
J Pharmacol Exp Ther; 2005 Aug; 314(2):906-15. PubMed ID: 15860577
[TBL] [Abstract][Full Text] [Related]
9. High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain.
Boja JW; Mitchell WM; Patel A; Kopajtic TA; Carroll FI; Lewin AH; Abraham P; Kuhar MJ
Synapse; 1992 Sep; 12(1):27-36. PubMed ID: 1411961
[TBL] [Abstract][Full Text] [Related]
10. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
Wall SC; Innis RB; Rudnick G
Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a recombinant human dopamine transporter in multiple cell lines.
Eshleman AJ; Neve RL; Janowsky A; Neve KA
J Pharmacol Exp Ther; 1995 Jul; 274(1):276-83. PubMed ID: 7616409
[TBL] [Abstract][Full Text] [Related]
12. Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterization.
Staley JK; Basile M; Flynn DD; Mash DC
J Neurochem; 1994 Feb; 62(2):549-56. PubMed ID: 8294917
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and transporter binding properties of 3beta-[4'-(phenylalkyl, -phenylalkenyl, and -phenylalkynyl)phenyl]tropane-2beta-carboxylic acid methyl esters: evidence of a remote phenyl binding domain on the dopamine transporter.
Blough BE; Keverline KI; Nie Z; Navarro H; Kuhar MJ; Carroll FI
J Med Chem; 2002 Aug; 45(18):4029-37. PubMed ID: 12190324
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters.
Eshleman AJ; Nagarajan S; Wolfrum KM; Reed JF; Swanson TL; Nilsen A; Janowsky A
Psychopharmacology (Berl); 2019 Mar; 236(3):939-952. PubMed ID: 30397775
[TBL] [Abstract][Full Text] [Related]
15. Selective labeling of the dopamine transporter by the high affinity ligand 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylic acid isopropyl ester.
Boja JW; Cadet JL; Kopajtic TA; Lever J; Seltzman HH; Wyrick CD; Lewin AH; Abraham P; Carroll FI
Mol Pharmacol; 1995 Apr; 47(4):779-86. PubMed ID: 7723739
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and transporter binding properties of 2,3-diphenyltropane stereoisomers. Comparison to 3beta-phenyltropane-2beta-carboxylic acid esters.
Chang AC; Burgess JP; Mascarella SW; Abraham P; Kuhar MJ; Carroll FI
J Med Chem; 1997 Apr; 40(8):1247-51. PubMed ID: 9111298
[TBL] [Abstract][Full Text] [Related]
17. Assessment of affinities of beta-CIT, beta-CIT-FE, and beta-CIT-FP for monoamine transporters permanently expressed in cell lines.
Okada T; Fujita M; Shimada S; Sato K; Schloss P; Watanabe Y; Itoh Y; Tohyama M; Nishimura T
Nucl Med Biol; 1998 Jan; 25(1):53-8. PubMed ID: 9466362
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor.
Skolnick P; Popik P; Janowsky A; Beer B; Lippa AS
Eur J Pharmacol; 2003 Feb; 461(2-3):99-104. PubMed ID: 12586204
[TBL] [Abstract][Full Text] [Related]
19. Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters.
Miller DK; Crooks PA; Zheng G; Grinevich VP; Norrholm SD; Dwoskin LP
J Pharmacol Exp Ther; 2004 Sep; 310(3):1035-45. PubMed ID: 15121762
[TBL] [Abstract][Full Text] [Related]
20. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
Wall SC; Gu H; Rudnick G
Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]